Genomic testing startup Viome closes $86.5M round, partners with CVS to sell at-home kits

Seattle-area health tech startup Viome Life Sciences, which sells at-home kits that analyze the microbial composition of stool samples and provides food recommendations, as well as supplements and probiotics, closed a $86.5 million Series C round and announced a deal with CVS to sell its gut microbiome test in 200 CVS locations across the U.S.